Assembly Biosciences (ASMB) Retained Earnings (2010 - 2026)
Assembly Biosciences (ASMB) recorded quarterly Retained Earnings of -$841.1 million in Q1 2026, down 1.09% quarter-over-quarter from -$832.0 million in Q4 2025, and down 0.76% on a YoY basis from -$847.6 million in Q1 2025.
Assembly Biosciences (ASMB) Retained Earnings (2010 - 2026) Analysis & Trends
Assembly Biosciences' Retained Earnings history runs 17 years deep, the most recent figure standing at -$841.1 million for Q1 2026.
- In Q1 2026, Retained Earnings fell 0.76% year-over-year to -$841.1 million; the TTM figure through Mar 2026 stood at -$841.1 million (down 0.76% YoY), while the FY2025 annual figure was -$832.0 million, down 394235.07% from the prior year.
- Retained Earnings was -$841.1 million for Q1 2026 at Assembly Biosciences, down from -$832.0 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of -$81000.0 in Q4 2023 to a low of -$854.1 million in Q3 2025.
- Historically, Retained Earnings has averaged -$559.2 million across 5 years, with a median of -$774.8 million in 2023.
- The sharpest annual moves came in 2023 and 2025: Retained Earnings surged 99.99% in 2023, then plunged 394235.07% in 2025.
- A 5-year view of Retained Earnings shows it stood at -$724.5 million in 2022, then soared by 99.99% to -$81000.0 in 2023, then sank by 160.49% to -$211000.0 in 2024, then slumped by 394235.07% to -$832.0 million in 2025, then declined by 1.09% to -$841.1 million in 2026.
- The last three Retained Earnings figures came in at -$841.1 million (Q1 2026), -$832.0 million (Q4 2025), and -$854.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 130.89 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -279.00 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -838.07 Mn |
| 10 | Assembly Biosciences | 418.96 Mn | 192.36 Mn | - | -841.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -841.13 Mn |
| Dec 31, 2025 | -832.05 Mn |
| Sep 30, 2025 | -854.14 Mn |
| Jun 30, 2025 | -844.94 Mn |
| Mar 31, 2025 | -834.74 Mn |
| Dec 31, 2024 | -211,000.00 |
| Sep 30, 2024 | -815.59 Mn |
| Jun 30, 2024 | -805.98 Mn |
| Mar 31, 2024 | -794.83 Mn |
| Dec 31, 2023 | -81,000.00 |
| Sep 30, 2023 | -774.79 Mn |
| Jun 30, 2023 | -325,000.00 |
| Mar 31, 2023 | -513,000.00 |
| Dec 31, 2022 | -724.52 Mn |
| Sep 30, 2022 | -702.13 Mn |
| Jun 30, 2022 | -678.98 Mn |
| Mar 31, 2022 | -908,000.00 |
| Dec 31, 2021 | -419,000.00 |
| Sep 30, 2021 | -571.17 Mn |
| Jun 30, 2021 | -273,000.00 |